Specific Profile of Tau Isoforms in Argyrophylic Grain Disease

Overview

Journal J Exp Neurosci

Publisher Sage Publications

Specialty Neurology

Date 2014 Aug 27

PMID 25157208

Citations 2

Authors

Alberto Rabano

Raquel Cuadros

Miguel Calero

Felix Hernandez

Jesus Avila

Affiliations

Soon will be listed here.

Abstract

Argyrophylic grain disease (AGD) is a neurodegenerative condition that has been classified among the sporadic tauopathies. Entities in this group present intracellular aggregates of hyperphosphorylated tau, giving rise to characteristic neuronal and glial inclusions. In different tauopathies, the proportion of several tau isoforms present in the aggregates shows specific patterns. AGD has been tentatively classified in the 4R group (predominance of 4R tau isoforms) together with progressive supranuclear palsy and corticobasal degeneration. Pick's disease is included in the 3R group (predominance of 3R isoforms), whereas tau pathology of Alzheimer's disease represents and intermediate group (3 or 4 repeats [3R plus 4R, respectively] isoforms). In this work, we have analyzed tau present in aggregates isolated from brain samples of patients with argyrophylic grain disease. Our results indicate that the main tau isoform present in aggregates obtained from patients with AGD is a hyperphosphorylated isoform containing exons 2 and 10 but lacking exon 3.

Citing Articles

The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?.

Fichou Y, Al-Hilaly Y, Devred F, Smet-Nocca C, Tsvetkov P, Verelst J Acta Neuropathol Commun. 2019; 7(1):31.

PMID: 30823892 PMC: 6397507. DOI: 10.1186/s40478-019-0682-x.

Tau Structures.

Avila J, Jimenez J, Sayas C, Bolos M, Zabala J, Rivas G Front Aging Neurosci. 2016; 8:262.

PMID: 27877124 PMC: 5099159. DOI: 10.3389/fnagi.2016.00262.

References

Tolnay M, Clavaguera F . Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. Neuropathology. 2005; 24(4):269-83. DOI: 10.1111/j.1440-1789.2004.00591.x. View

Zhong Q, Congdon E, Nagaraja H, Kuret J . Tau isoform composition influences rate and extent of filament formation. J Biol Chem. 2012; 287(24):20711-9. PMC: 3370253. DOI: 10.1074/jbc.M112.364067. View

Ikeda K, Akiyama H, Kondo H, Haga C . A study of dementia with argyrophilic grains. Possible cytoskeletal abnormality in dendrospinal portion of neurons and oligodendroglia. Acta Neuropathol. 1995; 89(5):409-14. DOI: 10.1007/BF00307644. View

Kwok J, Teber E, Loy C, Hallupp M, Nicholson G, Mellick G . Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol. 2004; 55(3):329-34. DOI: 10.1002/ana.10826. View

Short R, Graff-Radford N, Adamson J, Baker M, Hutton M . Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol. 2002; 59(4):611-5. DOI: 10.1001/archneur.59.4.611. View

Kovacs G, Gelpi E, Lehotzky A, Hoftberger R, Erdei A, Budka H . The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol. 2006; 113(2):153-61. DOI: 10.1007/s00401-006-0167-4. View

Hoe H, Freeman J, Rebeck G . Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons. Mol Neurodegener. 2006; 1:18. PMC: 1713232. DOI: 10.1186/1750-1326-1-18. View

Lee V, Goedert M, Trojanowski J . Neurodegenerative tauopathies. Annu Rev Neurosci. 2001; 24:1121-59. DOI: 10.1146/annurev.neuro.24.1.1121. View

Ding Z, Wang Y, Jiang Y, Yoshida M, Mimuro M, Inagaki T . Argyrophilic grain disease: frequency and neuropathology in centenarians. Acta Neuropathol. 2006; 111(4):320-8. DOI: 10.1007/s00401-006-0043-2. View

10.

Togo T, Sahara N, Yen S, Cookson N, Ishizawa T, Hutton M . Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol. 2002; 61(6):547-56. DOI: 10.1093/jnen/61.6.547. View

11.

Caffrey T, Joachim C, Wade-Martins R . Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. Neurobiol Aging. 2007; 29(12):1923-9. PMC: 2801070. DOI: 10.1016/j.neurobiolaging.2007.05.002. View

12.

Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C . MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet. 2012; 21(18):4094-103. PMC: 3428157. DOI: 10.1093/hmg/dds238. View

13.

Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S . Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative study. Am J Pathol. 2002; 161(4):1135-41. PMC: 1867288. DOI: 10.1016/s0002-9440(10)64390-8. View

14.

Garcia-Martin E, Martinez C, Alonso-Navarro H, Benito-Leon J, Lorenzo-Betancor O, Pastor P . H1-MAPT and the risk for familial essential tremor. PLoS One. 2012; 7(7):e41581. PMC: 3402423. DOI: 10.1371/journal.pone.0041581. View

15.

Calero O, Bullido M, Clarimon J, Frank-Garcia A, Martinez-Martin P, Lleo A . Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases. PLoS One. 2011; 6(7):e22090. PMC: 3140492. DOI: 10.1371/journal.pone.0022090. View

16.

Goedert M, Spillantini M, Cairns N, Crowther R . Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 1992; 8(1):159-68. DOI: 10.1016/0896-6273(92)90117-v. View

17.

Grinberg L, Wang X, Wang C, Sohn P, Theofilas P, Sidhu M . Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation. Acta Neuropathol. 2013; 125(4):581-93. PMC: 3692283. DOI: 10.1007/s00401-013-1080-2. View

18.

Masliah E, Hansen L, Quijada S, DeTeresa R, Alford M, Kauss J . Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?. Ann Neurol. 1991; 29(4):389-96. DOI: 10.1002/ana.410290409. View

19.

Sergeant N, WATTEZ A, Delacourte A . Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem. 1999; 72(3):1243-9. DOI: 10.1046/j.1471-4159.1999.0721243.x. View

20.

Ikeda K, Akiyama H, Arai T, Matsushita M, Tsuchiya K, Miyazaki H . Clinical aspects of argyrophilic grain disease. Clin Neuropathol. 2000; 19(6):278-84. View